Toxicity Considerations and Treatment Decisions in CRC : vim

Experts on colorectal cancer discuss the treatment decision-making process, highlighting the safety profiles of fruquintinib and regorafenib.

Related Keywords

, Adverse Event Management , Colorectal Cancer , Optimizing Treatment Approaches , Treatment Decisions , Crc , Colorectal Cancer Treatment , Mcrc Treatment , Fruquintinib , Regorafenib , Toxicity , Safety Profile , Vegf , Fresco 2 ,